Edwin M Horwitz (Edwin Horwitz)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 4

Top Topics

Acute Lymphoblastic Leukemia

Emergency Department

Top Venues

Nature medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Bruce L Levine, Marcelo C Pasquini, John E Connolly, David L Porter, Michael P Gustafson, Jaap-Jan Boelens, Edwin M Horwitz, Stephan A Grupp, Marcela V Maus, Frederick L Locke, Fabio Ciceri, Annalisa Ruggeri, John A Snowden, Helen E Heslop, Crystal L Mackall, Carl H June, Anna M Sureda, Miguel-Ángel Perales
Unanswered questions following reports of secondary malignancies after CAR-T cell therapy. Nature medicine 30 (2) (2024)
Bruce L Levine, Marcelo C Pasquini, John E Connolly, David L Porter, Michael P Gustafson, Jaap-Jan Boelens, Edwin M Horwitz, Stephan A Grupp, Marcela V Maus, Frederick L Locke, Fabio Ciceri, Annalisa Ruggeri, John A Snowden, Helen E Heslop, Crystal L Mackall, Carl H June, Anna M Sureda, Miguel-Ángel Perales
Unanswered questions following reports of secondary malignancies after CAR-T cell therapy. Nature medicine (2024)
Bruce L Levine, Marcelo C Pasquini, John E Connolly, David L Porter, Michael P Gustafson, Jaap-Jan Boelens, Edwin M Horwitz, Stephan A Grupp, Marcela V Maus, Frederick L Locke, Fabio Ciceri, Annalisa Ruggeri, John A Snowden, Helen E Heslop, Crystal L Mackall, Carl H June, Anna M Sureda, Miguel-Ángel Perales
Unanswered questions following reports of secondary malignancies after CAR-T cell therapy. Nature medicine 30 (2) (2024)
Sanyukta Janardan, Edwin M Horwitz, Benjamin Watkins, Kirsten Williams, Shanmuganathan Chandrakasan, Muna Qayed, Suhag H Parikh, Staci D Arnold, Frank Keller, Adina Alazraki, Michelle L Schoettler, Kathryn Leung
Blinatumomab induces complete response in refractory PTLD after hematopoietic cell transplantation. Blood advances 6 (10) (2022)